BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17145956)

  • 1. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
    Berruyer C; Pouyet L; Millet V; Martin FM; LeGoffic A; Canonici A; Garcia S; Bagnis C; Naquet P; Galland F
    J Exp Med; 2006 Dec; 203(13):2817-27. PubMed ID: 17145956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores.
    Martin F; Penet MF; Malergue F; Lepidi H; Dessein A; Galland F; de Reggi M; Naquet P; Gharib B
    J Clin Invest; 2004 Feb; 113(4):591-7. PubMed ID: 14966568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
    Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
    Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa.
    Voltan S; Martines D; Elli M; Brun P; Longo S; Porzionato A; Macchi V; D'Incà R; Scarpa M; Palù G; Sturniolo GC; Morelli L; Castagliuolo I
    Gastroenterology; 2008 Oct; 135(4):1216-27. PubMed ID: 18722375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
    Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
    Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease].
    Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P
    Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
    Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
    Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
    Okamoto T; Uemoto S; Tabata Y
    J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystamine restores GSTA3 levels in Vanin-1 null mice.
    Di Leandro L; Maras B; Schininà ME; Dupré S; Koutris I; Martin FM; Naquet P; Galland F; Pitari G
    Free Radic Biol Med; 2008 Mar; 44(6):1088-96. PubMed ID: 18206125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
    Shah YM; Morimura K; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
    Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
    Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
    Ponferrada A; Caso JR; Alou L; Colón A; Sevillano D; Moro MA; Lizasoain I; Menchén P; Gómez-Lus ML; Lorenzo P; Cos E; Leza JC; Menchén L
    Gastroenterology; 2007 May; 132(5):1791-803. PubMed ID: 17484875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.